Login / Signup

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.

Timothy DonnisonJoey McGregorSenthil K ChinnakannanClaire L HutchingsRob J CenterPantelis PoumbouriosPaul KlenermanHeidi E DrummerEleanor Barnes
Published in: Hepatology (Baltimore, Md.) (2022)
These data are an important step forward for the development of a pan-genotype HCV vaccine to elicit T cells and nAbs for future assessment in humans.
Keyphrases
  • hepatitis c virus
  • human immunodeficiency virus
  • sars cov
  • electronic health record
  • big data
  • high fat diet induced
  • type diabetes
  • dengue virus
  • metabolic syndrome
  • data analysis